EDSA
Edesa Biotech Inc
-24.09%
$1.37 - $1.04
Feb 7th 2023 - Mar 21st 2023
Jan, 11, 2023
$EDSA It certainly is an interesting development.
Jan, 6, 2023
$EDSA strong accumulation in 2-2.50 range; indep... See more
OCGN
Ocugen Inc
-23.15%
$1.24 - $0.95
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
Any positive development is just going to solidify... See more
Feb, 7, 2023
They worked with leading experts in the field to d... See more
Jan, 11, 2023
$EDSA It certainly is an interesting development.
Jan, 6, 2023
$EDSA strong accumulation in 2-2.50 range; independent of economic/rate developments and string P2 results all point to a significant upside in the next month.
Nov, 13, 2022
A positive development in terms of upcoming P2 data.
Mar, 17, 2023
Any positive development is just going to solidify the uptrend that is taking place on the technicals $JNJ $ABBV $OCGN $APLS
Feb, 7, 2023
They worked with leading experts in the field to develop innovative therapies for a range of ocular diseases, and their products were met with great excitement and anticipation.
Jan, 12, 2023
$OCGN “We are eager to get started on the final phase of NeoCart® development and pleased at the outcome of our discussions with the FDA”
Dec, 27, 2022
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics,” said Krishna Ella, executive chairman of Bharat Biotech.
Oct, 3, 2022
Revenue means security for future development and ocgn’s whole pipeline will gain value because of it.